Anolinx to Announce Plan to Bring New Medicines to Market Faster

Anolinx to launch patient recruitment initiative designed to bring new medicines to market faster in conjunction with the Partnerships in Clinical Trials Conference in Orlando, FL

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Anolinx Clinical Research and Clinical Trials Recruitment

Clinical Research and Clinical Trials Recruitment

a new patient recruitment initiative designed to break the clinical trials recruitment logjam and bring new medicines to market faster

Orlando, FL (PRWEB) April 19, 2013

WHY: Anolinx™ will launch a new patient recruitment initiative designed to break the clinical trials recruitment logjam and bring new medicines to market faster.

Chairman of the Board, Senator Robert F. Bennett (Ret.), and Anolinx CEO, Aaron Kamauu, MD MS MPH, will be discussing the launch. Dr. Kamauu, Senator Bennett, and Raymond L. Woosley, MD PhD, Chairman of the Anolinx™ Board of Scientific Advisors, will be available for individual interviews.

WHAT: News Conference and Reception in conjunction with the Partnerships in Clinical Trials conference in Orlando, FL.

WHERE: Orlando World Center Marriott, Suite 21290, Orlando FL

WHEN: Tuesday, April 23. Reception begins at 6:30 p.m. News Conference at 7:00 p.m.

ABOUT ANOLINX
Anolinx™ is a data-driven clinical research and clinical trials recruitment company that digs deep into electronic health records to significantly improve recruitment and reduce the cost and time for completion of clinical trials. Our unprecedented access to current real-world healthcare data and our advanced analytics enable us to recruit clinical trial patients faster and with greater precision so that our clients can get new medicines to market sooner.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus